FinanceMarketWatch.com - Top StoriesJaimy Lee
Most FDA advisers say peptides like BPC-157 and TB-500 should be made available in the U.S. Here’s what happens next.
At a glance
The FDA is deciding whether seven peptides can be legally compounded, potentially opening the door to broader use in Americans.
- Primary source
- MarketWatch.com - Top Stories — Read original article
- Published
- Topic
- Finance
The FDA is deciding whether seven peptides can be legally compounded, potentially opening the door to broader use in Americans.
This summary comes from MarketWatch.com - Top Stories. Read the full article at the original source.
References
More in Finance
FinanceMarketWatch.com - Top Stories
Let’s elect candidates who will make the wealthy pay taxes
We can use some of those revenues to make Social Security contributions more equitable.
Alicia H. Munnell
FinanceMarketWatch.com - Top Stories
‘Don’t get suckered like I did’: I paid $185 to the wrong passport website. Can I get my money back?
“I will file a complaint with the Better Business Bureau.”
Quentin Fottrell
TrumpMarketWatch.com - Top Stories
Rising Medicare Part D premiums could drive more people into Medicare Advantage plans
Medicare Advantage plans could be the winners of a decision by the Trump administration to put an early end to a program that kept the cost of Medicare prescription drug plans…
Jessica Hall
FinanceMarketWatch.com - Top Stories
Americans are living longer than our retirement system can handle — and many of us are unprepared
Watch out for these 4 major financial pitfalls.
Edd and Cynthia Staton